Cargando…
Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One Vaccination
We present here a 64-year-old male participant of the CoNAN study who experienced a PCR-confirmed mild SARS-CoV-2 infection but did not develop any measurable antibody response. Additionally, after vaccination with ChAdOx1 (AstraZeneca, Cambridge, UK) 11 months later, no antibodies were detected in...
Autores principales: | Andreas, Nico, Weis, Sebastian, Kolanos, Steffi, Baumgart, Sabine, Kamradt, Thomas, Pletz, Mathias W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780102/ https://www.ncbi.nlm.nih.gov/pubmed/35062775 http://dx.doi.org/10.3390/vaccines10010114 |
Ejemplares similares
-
Persistent humoral and CD4(+) T(H) cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
por: Schnizer, Clara, et al.
Publicado: (2023) -
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021) -
Group Vaccination Five Days before a COVID-19 Outbreak in a Long-Term Care Facility
por: Pletz, Mathias W., et al.
Publicado: (2021) -
Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection
por: Glöckner, Stefan, et al.
Publicado: (2021) -
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak—the CoNAN study
por: Weis, Sebastian, et al.
Publicado: (2021)